Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 59 Show results per page	View Search Criteria \| Help With Results


1.		Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 to 85				Other				20050113 NCT00243685

Last Modified: 10/10/2008 First Published: 3/24/2005


2.		Phase III Randomized Study of Sublobar Resection With Versus Without Intraoperative Brachytherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ACOSOG-Z4032 ACOSOG-Z4032, NCT00107172

Last Modified: 10/10/2008 First Published: 5/5/2006


3.		Phase III Randomized Study of Adjuvant Chemotherapy With or Without Bevacizumab in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ECOG-E1505 E1505, SWOG-E1505, CALGB-E1505, CAN-NCIC-E1505, NCCTG-E1505, NCT00324805


4.		RADIANT: A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) - Positive Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				OSI-774-302 NCT00373425


5.		GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				109493 NCT00480025

Last Modified: 10/8/2008 First Published: 7/6/2007


6.		Phase III Randomized Study of Lobectomy Versus Sublobar Resection in Patients With Small Peripheral Stage IA Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-140503 CALGB-140503, ECOG-40503, NCT00499330


7.		Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Diagnostic, Treatment				Approved-not yet active				18 and over				Other				05-219 NCT00264602


8.		DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Diagnostic, Treatment				Active				No age specified				Other				A/100/0601 NCT00298298


9.		A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				9031 H3E-US-S047, NCT00482014


10.		A Phase I/II Trial of Stereotactic Body Radiation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				Over 18				Other				06-0691 NCT00591838

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute